(1-Ethylpiperidin-4-yl)methanol
97%
- Product Code: 74161
CAS:
90226-87-2
Molecular Weight: | 143.23 g./mol | Molecular Formula: | C₈H₁₇NO |
---|---|---|---|
EC Number: | MDL Number: | ||
Melting Point: | Boiling Point: | 210°C | |
Density: | Storage Condition: | 2-8°C |
Product Description:
This chemical is primarily utilized in the synthesis of pharmaceutical compounds, particularly in the development of central nervous system (CNS) drugs. It serves as a key intermediate in the production of antipsychotic and anticholinergic medications, where its piperidine structure is crucial for binding to specific receptors in the brain. Additionally, it is employed in the creation of ligands for receptor studies, aiding in the understanding of neurological pathways and drug interactions. Its application extends to research and development in medicinal chemistry, where it is used to design and optimize novel therapeutic agents targeting neurological disorders.
Product Specification:
Test | Specification |
---|---|
APPEARANCE | Colorless to White to off-white Liquid |
PURITY | 94.5-100 |
Infrared spectrum | Conforms to Structure |
NMR | Conforms to Structure |
Sizes / Availability / Pricing:
Size (g) | Availability | Price | Quantity |
---|---|---|---|
0.250 | 10-20 days | $70.45 |
+
-
|
1.000 | 10-20 days | $140.42 |
+
-
|
5.000 | 10-20 days | $544.78 |
+
-
|
(1-Ethylpiperidin-4-yl)methanol
This chemical is primarily utilized in the synthesis of pharmaceutical compounds, particularly in the development of central nervous system (CNS) drugs. It serves as a key intermediate in the production of antipsychotic and anticholinergic medications, where its piperidine structure is crucial for binding to specific receptors in the brain. Additionally, it is employed in the creation of ligands for receptor studies, aiding in the understanding of neurological pathways and drug interactions. Its application extends to research and development in medicinal chemistry, where it is used to design and optimize novel therapeutic agents targeting neurological disorders.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :